Lipocine Inc. Net Income Loss

• Lipocine Inc. showed a decrease of -115,371.9% in Net Income Loss from 2024 to 2025.
• This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2011 to 2025), Lipocine Inc.'s Net Income Loss has declined by 186,407.3%.
• Historical annual values: Fiscal year 2025: -$9.63 million | Fiscal year 2024: $8.4 thousand | Fiscal year 2023: -$16.35 million | Fiscal year 2022: -$10.76 million | Fiscal year 2021: -$634.4 thousand | Fiscal year 2020: -$20.96 million | Fiscal year 2019: -$13.01 million | Fiscal year 2018: -$11.66 million | Fiscal year 2017: -$20.98 million | Fiscal year 2016: -$18.97 million | Fiscal year 2015: -$18.21 million | Fiscal year 2014: -$20.37 million | Fiscal year 2013: -$10.59 million | Fiscal year 2012: $3.89 million | Fiscal year 2011: -$5.2 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026